When British pharmaceutical company AstraZeneca admitted in court that this vaccine could have rare of the rarest side effects. Right after that, there is an uproar in India also regarding the Covishield vaccine. AstraZeneca Pharma Company admitted that their Covishield vaccine may also have side effects. In which blood clots form in the body and platelet counts fall or can cause heart attack.
Covishield was made by serum company in India
Now Serum Institute has also issued a statement on the side effects of AstraZeneca and Covishield. Serum Institute has stated that the rarest of the rare side effects on TTS were already disclosed on all their product packaging.
The company said that Covishield has saved lives of people all over the world. Let us tell you that recently AstraZeneca has accepted the connection between the vaccine and thrombosis with thrombocytopenia syndrome.
This is a condition in which the level of platelets becomes abnormally lower than normal and blood clots start forming in the body.
Covishield will not be manufactured from December 2021
Serum Institute said that we completely understand these concerns. But transparency and security are most important for us. We disclosed several side effects, including thrombosis with thrombocytopenia syndrome, in a packaging insert in 2021.
The world’s largest vaccine company clearly said that due to the mutation of new variants of Corona, we have stopped making Covishield from December 2021. Due to which the demand for vaccines in the market had reduced considerably. The highest number of vaccinations took place in India in the years 2021 and 2022. After this new variants of Corona emerged.